You're signed outSign in or to get full access.
Sofinnova Investments, Inc.
CIK:0001631134
Venture Capital
$4B AUM
63 holdings
Menlo Park, CA, USA
Sofinnova Investments is a venture capital firm focused on early-stage life science and IT companies.
Investment Strategy
Early-stage life science and IT investments
Latest 13F Filing Activity
Sofinnova Investments, Inc. filed their most recent 13F report on Jun 30, 2025 disclosing 55 equity positions and 8 options positions with a total 13F market value of $2B. The fund increased holdings in Gilead Sciences Inc., Abbvie Inc., Boston Scientific Corp. among other positions. Sofinnova Investments, Inc. reduced exposure to Stryker Corporation, Medtronic PLC, Alnylam Pharmaceuticals Inc. among others.
Top Buys
Top Holdings
Equity Positions (55)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
N NTRA | Natera Inc | 16.02% | $261.9M | 1,550,280 | $9.35 | $168.94 | +$42.7M |
G GILD | Gilead Sciences Inc | 7.12% | $116.4M | 1,050,308 | $103.49 | $110.87 | +$69.5M |
L LLY | Eli Lilly and Co | 4.63% | $75.6M | 97,018 | $796.79 | $779.53 | +$32.0M |
J JAZZ | Jazz Pharmaceuticals PLC | 4.50% | $73.7M | 694,096 | $115.45 | $106.12 | +$10.3M |
V VERA | Vera Therapeutics Inc | 4.03% | $65.8M | 2,793,987 | $13.59 | $23.56 | -$1.3M |
Options Positions (8)
| Ticker | Security | Action | Type | Notional Value | Contracts | Underlying Price | Premium Paid | Change (Contracts) | Change (Value) |
|---|---|---|---|---|---|---|---|---|---|
I IWM | iShares TR | Sold | Put | $53.9M | 2,500 | $215.79 | $199.49 | -1,000 | -$15.9M |
I IBB | iShares TR | New | Put | $47.4M | 3,750 | $126.51 | $126.51 | +3,750 | +$47.4M |
S SMMT | Summit Therapeutics Inc | New | Call | $14.9M | 7,000 | $21.28 | $21.28 | +7,000 | +$14.9M |
R RYTM | Rhythm Pharmaceuticals Inc | New | Put | $14.2M | 2,250 | $63.19 | $63.19 | +2,250 | +$14.2M |
R REPL | Replimune Group Inc | New | Put | $13.9M | 15,000 | $9.29 | $9.29 | +15,000 | +$13.9M |
Industry Allocation
PHARMACEUTICAL PREPARATIONS
+57.0%
SERVICES-MEDICAL LABORATORIES
+15.4%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+12.2%
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
+7.3%
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
+2.7%
Investment Team (13)
| Name | Role | Location | |
|---|---|---|---|
 | Analyst | New York, NY , United States | |
 | Partner | New York, NY , United States | |
 | General Partner | CA , United States | |
J John Barrett | Analyst | Boston, MA , United States | |
 | Analyst | CA , United States | |
S Sarah Bhagat | General Partner | Menlo Park, CA , United States | |
A Ace Isidro | Associate | Boston, MA , United States | |
 | Analyst | Boston, MA , United States | |
 | Managing Partner | United States | |
 | Fund Manager | Ashburn, VA , United States |
Showing 1-10 of 13 team members
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more